secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oric Pharmaceuticals, Inc. (ORIC)
CIK:        0001796280
Form:       8-K
Filed at:   2021-11-10T23:59:59+00:00
Accession:  0001193125-21-326034
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ORIC Pharmaceuticals appoints Angie You to board, Carl Gordon resigns
---------------------------------------------------------------------

- Carl Gordon, Ph.D., CFA, resigned as director voluntarily, no disagreement with board.
- Angie You, Ph.D., appointed as Class II director, term expires at 2022 annual meeting.
- You is CEO of Amunix Pharmaceuticals; previously chief business officer at Sierra Oncology and Aragon.
- She receives annual cash retainer of $35,000, committee fees, and stock option for 33,250 shares.
- No reportable transactions under Item 404(a) between You and ORIC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1796280/000119312521326034/0001193125-21-326034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1796280/000119312521326034/d241352d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-326034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer